In 2009 Straumann® unveiled its Roxolid® implant material, which has introduced an innovation to the market and set new standards in terms of combining strength and excellent osseointegration. Since then, new possibilities have opened up for implant treatment. Based on past experiences and the great success of Roxolid®, Straumann has developed a new, small diameter implant system: the Straumann® Standard Plus Narrow Neck CrossFit® (NNC) implant line. This new soft tissue level solution offers a broad range of prosthetic applications for narrow interdental spaces and limited bone availability and is opening up new treatment options. The new implant combines proven concepts with the latest technical innovations from Straumann®: the soft tissue level implant philosophy, SLActive® surface technology and Roxolid® material.
iPad® es una marca registrada de Apple Inc. registrada en EE.UU. y en otros países.